跳至主要内容
临床试验/JPRN-UMIN000014312
JPRN-UMIN000014312招募中未知

Examination of efficacy of tolvaptan for chronic congective heart failure complicated with chronic kidney disease. - TOLVAPTAN study

Department of Cardiology, Gifu University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2014年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who had acute myocardial infarction within 30 days . Patients of active myocarditis or the amyloid cardiomyopathy. Patients who are supported by circulation device. Patients who had decrease in circulation blood volume. Patients with hypertrophic cardiomyopathy (except the expansion aspect). Patients with severe valvular disease. Patients with hepatogenic comatose. Patients with insufficient treatment on diabetes mellitus. Patients whose blood pressure is less than 90mmHg. Patients that following electrolytes abnormality is accepted. Serum Na>147mEq/L, serum K>5.5mEq/L Patients who cannot take oral formulation. Patients with a pregnant woman, a nursing girl, pregnant possibility or the intention to become pregnant. Patients that are recognized as inappropriate for this study.

研究者

发起方
Department of Cardiology, Gifu University Graduate School of Medicine

相似试验